MyCare - Patients: View your medical records securely online here.
Log in Learn More

Primary or Salvage Immune Tolerance Induction in Patients with Hemophilia A with Inhibitors Utilizing Alphanate®, Factor VIII/ von Willebrand Factor Complex (Human)

Description: Retrospective chart review study: Evaluate the rates of success, partial success and failure among hemophilia patients with inhibitors who received alphante as a part of either a primary or rescue ITI protocol.
IRB Number: xxxxx
Status: Enrolling
Principal Name: Peter Kouides, MD
Contact Name: Laura Braggins
Phone: (585) 922-5006